Treatment of Hypereosinophilic Syndrome with Cutaneous Involvement with the JAK Inhibitors Tofacitinib and Ruxolitinib

Brett King; Alfred Ian Lee; Jaehyuk Choi

doi:10.1016/j.jid.2016.10.044

Treatment of Hypereosinophilic Syndrome with Cutaneous Involvement with the JAK Inhibitors Tofacitinib and Ruxolitinib

Brett King^*, Alfred Ian Lee, Jaehyuk Choi

^*Corresponding author for this work

Dermatology

Research output: Contribution to journal › Article › peer-review

28 Scopus citations

Original language	English (US)
Pages (from-to)	951-954
Number of pages	4
Journal	Journal of Investigative Dermatology
Volume	137
Issue number	4
DOIs	https://doi.org/10.1016/j.jid.2016.10.044
State	Published - Apr 1 2017

ASJC Scopus subject areas

Biochemistry
Molecular Biology
Dermatology
Cell Biology

Access to Document

10.1016/j.jid.2016.10.044

Cite this

@article{16eb217b649b40d395604f53c03f69eb,

title = "Treatment of Hypereosinophilic Syndrome with Cutaneous Involvement with the JAK Inhibitors Tofacitinib and Ruxolitinib",

author = "Brett King and Lee, {Alfred Ian} and Jaehyuk Choi",

year = "2017",

month = apr,

day = "1",

doi = "10.1016/j.jid.2016.10.044",

language = "English (US)",

volume = "137",

pages = "951--954",

journal = "Journal of Investigative Dermatology",

issn = "0022-202X",

publisher = "Nature Publishing Group",

number = "4",

}

TY - JOUR

T1 - Treatment of Hypereosinophilic Syndrome with Cutaneous Involvement with the JAK Inhibitors Tofacitinib and Ruxolitinib

AU - King, Brett

AU - Lee, Alfred Ian

AU - Choi, Jaehyuk

PY - 2017/4/1

Y1 - 2017/4/1

UR - http://www.scopus.com/inward/record.url?scp=85015956860&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015956860&partnerID=8YFLogxK

U2 - 10.1016/j.jid.2016.10.044

DO - 10.1016/j.jid.2016.10.044

M3 - Article

C2 - 27887955

AN - SCOPUS:85015956860

VL - 137

SP - 951

EP - 954

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

SN - 0022-202X

IS - 4

ER -